1 active not recruiting, 1 completed, 1 recruiting, 1 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Refractory Pancreatic Carcinoma: new trials by email Literature Review of Refractory Pancreatic Carcinoma trials Research Report on Refractory Pancreatic Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors BET Bromodomain Inhibitor ZEN-3694, Computed Tomography, Core Biopsy - Advanced Malignant Solid Neoplasm, Locally Advanced Pancreatic Carcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 49 | 2022-11-16 | 2026-07-15 |
| Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas Entinostat, Molibresib - Advanced Lymphoma, Advanced Malignant Solid Neoplasm | Phase 1 | Withdrawn | National Cancer Institute (NCI) | 2020-09-18 | 2020-09-28 | |
| A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors TRPV6 Calcium Channel Inhibitor SOR-C13 - Advanced Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm | Phase 1 | Completed | M.D. Anderson Cancer Center | 11 | 2019-07-29 | 2023-11-18 |
| M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Berzosertib, Biopsy Specimen, Biospecimen Collection - Metastatic Colorectal Carcinoma, Metastatic Lung Small Cell Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 66 | 2016-07-22 | 2026-09-25 |
Pancreatic Neoplasms (4) · Colorectal Neoplasms (1) · Lung Neoplasms (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, T-Cell (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Small Cell Lung Carcinoma (1)
Digestive System Diseases (4) · Digestive System Neoplasms (4) · Endocrine Gland Neoplasms (4) · Endocrine System Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Pancreatic Diseases (4) · Adnexal Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Colonic Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
entinostat (2) · Biopsy, Large-Core Needle (1) · Biopsy, Needle (1) · Irinotecan (1) · SOR-C13 (1) · Specimen Handling (1) · berzosertib (1) · molibresib (1)
National Cancer Institute (NCI) (3) · M.D. Anderson Cancer Center (1)
United States (3)
Patricia M LoRusso (2) · Liza C Villaruz (1) · Siqing Fu (1)
UM1CA186689 (3), UM1CA186690 (1), UM1CA186704 (1), UM1CA186717 (1)